Embecta (FRA:JX7) Long-Term Debt : €1,464 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Long-Term Debt?

Embecta's Long-Term Debt for the quarter that ended in Mar. 2024 was €1,464 Mil.

Embecta's quarterly Long-Term Debt declined from Sep. 2023 (€1,493 Mil) to Dec. 2023 (€1,461 Mil) but then increased from Dec. 2023 (€1,461 Mil) to Mar. 2024 (€1,464 Mil).

Embecta's annual Long-Term Debt increased from Sep. 2021 (€0 Mil) to Sep. 2022 (€1,614 Mil) but then declined from Sep. 2022 (€1,614 Mil) to Sep. 2023 (€1,493 Mil).

Embecta Long-Term Debt Historical Data

The historical data trend for Embecta's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Long-Term Debt Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Long-Term Debt

1,614.08

1,493.48

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial											1,490.66	1,472.19	1,493.48	1,460.69	1,464.46

Embecta (FRA:JX7) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Embecta Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Embecta's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines